Little Green Pharma Ltd Stock

Equities

LGP

AU0000074924

Pharmaceuticals

Market Closed - Australian S.E. 02:10:45 2024-04-26 EDT 5-day change 1st Jan Change
0.125 AUD -3.85% Intraday chart for Little Green Pharma Ltd -7.41% -10.71%

Financials

Sales 2024 * 25.6M 16.72M 22.84M Sales 2025 * 29.8M 19.47M 26.59M Capitalization 37.69M 24.62M 33.63M
Net income 2024 * - 0 0 Net income 2025 * -3M -1.96M -2.68M EV / Sales 2024 * 1.41 x
Net cash position 2024 * 1.7M 1.11M 1.52M Net Debt 2025 * 1M 653K 892K EV / Sales 2025 * 1.3 x
P/E ratio 2024 *
-62.5 x
P/E ratio 2025 *
-12.5 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 64.99%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Little Green Pharma Ltd

1 day-3.85%
1 week-7.41%
Current month-10.71%
1 month-7.41%
3 months-13.79%
6 months-19.35%
Current year-10.71%
More quotes
1 week
0.13
Extreme 0.125
0.14
1 month
0.13
Extreme 0.125
0.15
Current year
0.12
Extreme 0.12
0.16
1 year
0.12
Extreme 0.12
0.21
3 years
0.12
Extreme 0.12
0.97
5 years
0.12
Extreme 0.12
1.02
10 years
0.12
Extreme 0.12
1.02
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder - 17-05-28
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 71 18-11-12
Director/Board Member - 18-11-12
Director/Board Member - 18-02-18
More insiders
Date Price Change Volume
24-04-26 0.125 -3.85% 89,025
24-04-24 0.13 -3.70% 66,623
24-04-23 0.135 +3.85% 36,227
24-04-22 0.13 -3.70% 184,398
24-04-19 0.135 -3.57% 118,405

Delayed Quote Australian S.E., April 26, 2024 at 02:10 am

More quotes
Little Green Pharma Ltd is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. The Company has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The Company focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.125 AUD
Average target price
0.17 AUD
Spread / Average Target
+36.00%
Consensus

Annual profits - Rate of surprise